From Innovation Mindsets To Incentives And COVID-19 Lessons: How EU Pharma Legislation Should Evolve

If the EU wants to become a more competitive space for innovation it can take a few lessons from both the US and the COVID-10 pandemic, say European pharma industry representatives. Fostering better communication between regulators and companies is just one example.